Publications

5543 Results

Historical background of vinca alkaloid research and areas of future interest.

Authors
IS Johnson
Journal / Conference
Cancer Chemotherapy Reports 52(4):455-461
Year
1968

Ultrastructural studies on tissue culture cells treated with vincristine (NSC-67574).

Authors
LJ Journey;J Burdman;P George
Journal / Conference
Cancer Chemotherapy Reports 52(4): 509- 517
Year
1968

Chemotherapeutic trials in patients with metastatic retinoblastoma.

Authors
D Lonsdale;DH Berry;TM Holcomb;AH Nora;MP Sullivan;WG Thurman;TJ Vietti
Journal / Conference
Cancer Chemotherapy Reports 52(6):631-634
Year
1968
Research Committee(s)
Head and Neck

Combination therapy including vincristine (NSC-67574) for malignant solid tumors in children.

Authors
CB Pratt;DH James Jr;CP Holton;D Pinkel
Journal / Conference
Cancer Chemotherapy Reports 52(4):489-495
Year
1968

Biochemical studies with vinca alkaloids.

Authors
FJ Richards
Journal / Conference
Cancer Chemotherapy Reports 52(4):463-467
Year
1968

Effect of vincristine (NSC-67574) on malignant solid tumors in children.

Authors
OS Selawry;JF Holland;IJ Wolman
Journal / Conference
Cancer Chemotherapy Reports 52(4):497-500
Year
1968

Vincristine (HSC-67574) therapy for Wilms' tumor.

Authors
MP Sullivan
Journal / Conference
Cancer Chemotherapy Reports 52(4): 481-483
Year
1968
Research Committee(s)
Genitourinary

Vincristine (HSC-67574) therapy for malignant solid tumors in children (except Wilms' tumor).

Authors
WW Sutow
Journal / Conference
Cancer Chemotherapy Reports 52(4):485-487
Year
1968

Neurophysiologic alterations induced by vincristine (NSC-67574).

Authors
W Tobin;SG Sandler
Journal / Conference
Cancer Chemo- therapy Reports 52(4):519-526
Year
1968

Chemotherapy for acute leukemia in children: Comparison of cyclophosphamide (NSC-26271) and 6-mercaptopurine (NSC-755)

Authors
DJ Fernbach
Journal / Conference
Cancer Chemotherapy Reports 51:381-387
Year
1967
Research Committee(s)
Leukemia